MedTrace Logo

Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Patients

NCT04168216 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31

Last updated 2025-10-02

No results posted yet for this study

Summary

The intention with the study is to have a better understanding of what happens to COPD patients' symptoms, lung function and markers of inflammation over 12 weeks. This information will increase the understanding of COPD and how to design new treatments for COPD in the future.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Sponsors & Collaborators

  • University of Oxford

    collaborator OTHER

  • AstraZeneca

    lead INDUSTRY

Principal Investigators

  • Mona Bafadhel, Professor · Respiratory Department Churchill Hospital Old Road OX3 7LE

Eligibility

Min Age
40 Years
Max Age
130 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2022-06-22
Completion
2022-06-22

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04168216 on ClinicalTrials.gov